These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31611349)

  • 21. Manogepix (APX001A)
    Arendrup MC; Chowdhary A; Jørgensen KM; Meletiadis J
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32660998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated chitin content reduces the susceptibility of Candida species to caspofungin.
    Walker LA; Gow NA; Munro CA
    Antimicrob Agents Chemother; 2013 Jan; 57(1):146-54. PubMed ID: 23089748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species.
    Locke JB; Almaguer AL; Zuill DE; Bartizal K
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6100-7. PubMed ID: 27480852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019).
    Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
    J Glob Antimicrob Resist; 2021 Sep; 26():117-127. PubMed ID: 34051400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
    Mohammadi F; Charkhchian M; Mirzadeh M
    BMC Oral Health; 2023 May; 23(1):261. PubMed ID: 37143002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.
    Katiyar S; Pfaller M; Edlind T
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2892-4. PubMed ID: 16870797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
    Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M
    J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
    Mokaddas EM; Al-Sweih NA; Khan ZU
    J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin Inhibitors Synergize with Manogepix to Kill Diverse Human Fungal Pathogens.
    Liston SD; Whitesell L; Kapoor M; Shaw KJ; Cowen LE
    J Fungi (Basel); 2022 Oct; 8(10):. PubMed ID: 36294667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020).
    Pfaller MA; Huband MD; Rhomberg PR; Bien PA; Castanheira M
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0102822. PubMed ID: 36286491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
    Gebremariam T; Alkhazraji S; Alqarihi A; Jeon HH; Gu Y; Kapoor M; Shaw KJ; Ibrahim AS
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
    Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
    Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of
    Petraitiene R; Petraitis V; Maung BBW; Mansbach RS; Hodges MR; Finkelman MA; Shaw KJ; Walsh TJ
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361304
    [No Abstract]   [Full Text] [Related]  

  • 39. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.